Goldman Sachs
OPTR

Goldman Sachs’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Goldman Sachs’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-104,513
Closed -$1.32M – 7007
2013
Q3 		$1.32M Buy
104,513
+71,266
+214% +$944K ﹤0.01% 4340
2013
Q2 		$481K Buy
+33,247
New +$484K ﹤0.01% 4974

Goldman Sachs's OPTR Position: Q4 2013 in Review

Goldman Sachs sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 104,513 shares — an estimated $1.32M sold.

Goldman Sachs first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $1.32M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Goldman Sachs reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Goldman Sachs sold 104,513 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $1.32M.
  • Goldman Sachs first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Goldman Sachs's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $1.32M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Goldman Sachs's 13F filing for Q4 2013, filed 14 Feb 2014.